These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 26718703)
21. Should Low-Molecular-Weight Heparin be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism? Senturk A; Ucar EY; Berk S; Ozlu T; Altınsoy B; Dabak G; Cakır E; Kadıoglu EE; Sen HS; Ozsu S; Clin Appl Thromb Hemost; 2016 May; 22(4):395-9. PubMed ID: 25630985 [TBL] [Abstract][Full Text] [Related]
22. Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism. Konstantinides SV; Vicaut E; Danays T; Becattini C; Bertoletti L; Beyer-Westendorf J; Bouvaist H; Couturaud F; Dellas C; Duerschmied D; Empen K; Ferrari E; Galiè N; Jiménez D; Kostrubiec M; Kozak M; Kupatt C; Lang IM; Lankeit M; Meneveau N; Palazzini M; Pruszczyk P; Rugolotto M; Salvi A; Sanchez O; Schellong S; Sobkowicz B; Meyer G J Am Coll Cardiol; 2017 Mar; 69(12):1536-1544. PubMed ID: 28335835 [TBL] [Abstract][Full Text] [Related]
23. Massive pulmonary embolism in pregnancy treated with catheter-directed tissue plasminogen activator. Pick J; Berlin D; Horowitz J; Winokur R; Sista AK; Lichtman AD A A Case Rep; 2015 Apr; 4(7):91-4. PubMed ID: 25827861 [TBL] [Abstract][Full Text] [Related]
24. Pharmacotherapy of pulmonary embolism. Mattioli AV Expert Opin Pharmacother; 2002 Dec; 3(12):1719-25. PubMed ID: 12472369 [TBL] [Abstract][Full Text] [Related]
26. Clinical efficacy of low dose recombinant tissue-type plasminogen activator for the treatment of acute intermediate-risk pulmonary embolism. Zhang LY; Gao BA; Jin Z; Xiang GM; Gong Z; Zhang TT; Lu HF; Wang YQ; Gong Y; Lu C; Huang WL Saudi Med J; 2018 Nov; 39(11):1090-1095. PubMed ID: 30397707 [TBL] [Abstract][Full Text] [Related]
27. Low-dose thrombolysis for submassive pulmonary embolism. Yilmaz ES; Uzun O J Investig Med; 2021 Dec; 69(8):1439-1446. PubMed ID: 34099544 [TBL] [Abstract][Full Text] [Related]
28. Paradoxical embolus illustrating speed of action of recombinant tissue plasminogen activator in massive pulmonary embolism. Madani H; Ransom PA Emerg Med J; 2007 Jun; 24(6):441. PubMed ID: 17513552 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of Rescue Thrombolysis in Cardiac Arrest Secondary to Suspected or Confirmed Pulmonary Embolism. Summers K; Schultheis J; Raiff D; Dahhan T Ann Pharmacother; 2019 Jul; 53(7):711-715. PubMed ID: 30700101 [TBL] [Abstract][Full Text] [Related]
30. Rationale and methodology for a multicentre randomised trial of fibrinolysis for pulmonary embolism that includes quality of life outcomes. Kline JA; Hernandez J; Hogg MM; Jones AE; Courtney DM; Kabrhel C; Nordenholz KE; Diercks DB; Rondina MT; Klinger JR Emerg Med Australas; 2013 Dec; 25(6):515-26. PubMed ID: 24224521 [TBL] [Abstract][Full Text] [Related]
31. Management of acute pulmonary embolism. Quadery R; Elliot CA; Hurdman J; Kiely DG; Maclean RM; Sabroe I; van Veen JJ; Condliffe R Br J Hosp Med (Lond); 2015 Oct; 76(10):C150-5. PubMed ID: 26457952 [No Abstract] [Full Text] [Related]
32. Percutaneous rheolytic thrombectomy for large pulmonary embolism: a promising treatment option. Chauhan MS; Kawamura A Catheter Cardiovasc Interv; 2007 Jul; 70(1):121-8. PubMed ID: 17421019 [TBL] [Abstract][Full Text] [Related]
33. Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial. Steering Committee Am Heart J; 2012 Jan; 163(1):33-38.e1. PubMed ID: 22172434 [TBL] [Abstract][Full Text] [Related]
35. Successful thrombolytic therapy of post-operative massive pulmonary embolism after ultralong cardiopulmonary resuscitation: a case report and review of literature. Yu Y; Zhai Z; Yang Y; Xie W; Wang C Clin Respir J; 2017 May; 11(3):383-390. PubMed ID: 26083151 [TBL] [Abstract][Full Text] [Related]